144 related articles for article (PubMed ID: 12719296)
1. Treatment of hypertrophic cardiomyopathy.
Penas-Lado M; Barriales-Villa R; Monserrat L
Circulation; 2003 Apr; 107(16):e110; auhor reply e110. PubMed ID: 12719296
[No Abstract] [Full Text] [Related]
2. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].
Hentati M; Ben Ameur I; Kechida Z; Charfeddine H; Hached L; Grati Z; Kammoun S
Tunis Med; 2003; 81 Suppl 8():675-9. PubMed ID: 14608758
[TBL] [Abstract][Full Text] [Related]
3. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
Cotiga D; Ehlert F; Sherrid M
Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272
[TBL] [Abstract][Full Text] [Related]
4. Sudden death and hypertrophic cardiomyopathy: a review.
Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
6. Implantable defibrillators in hypertrophic cardiomyopathy.
Grace A
Heart; 2009 May; 95(9):695-6. PubMed ID: 19282312
[No Abstract] [Full Text] [Related]
7. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].
Maron BJ
Rev Esp Cardiol; 2006 Jun; 59(6):527-30. PubMed ID: 16790193
[No Abstract] [Full Text] [Related]
8. Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy.
Jayatilleke I; Doolan A; Ingles J; McGuire M; Booth V; Richmond DR; Semsarian C
Am J Cardiol; 2004 May; 93(9):1192-4. PubMed ID: 15110224
[TBL] [Abstract][Full Text] [Related]
9. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
Maron BJ; Estes NA; Maron MS; Almquist AK; Link MS; Udelson JE
Circulation; 2003 Jun; 107(23):2872-5. PubMed ID: 12814983
[No Abstract] [Full Text] [Related]
10. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
Maron BJ
Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
[No Abstract] [Full Text] [Related]
11. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Raj SR; Mitchell LB; Sheldon RS
N Engl J Med; 2000 Jul; 343(1):68-9. PubMed ID: 10896549
[No Abstract] [Full Text] [Related]
12. [Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator].
Manovel-Sánchez AJ; Pedrote-Martínez A; Arana-Rueda E; Errazquin-Sáenz de Tejada F
Rev Esp Cardiol; 2007 Jul; 60(7):784; author reply 785. PubMed ID: 17663866
[No Abstract] [Full Text] [Related]
13. Sudden death in hypertrophic cardiomyopathy.
Watkins H
N Engl J Med; 2000 Feb; 342(6):422-4. PubMed ID: 10666434
[No Abstract] [Full Text] [Related]
14. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
[No Abstract] [Full Text] [Related]
15. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation].
Jastrzebski M; Czarnecka D; Bacior B; Petkow-Dimitrow P; Wilczek R; Kawecka-Jaszcz K
Kardiol Pol; 2005 Aug; 63(2):191-5; discussion 196. PubMed ID: 16136416
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
[TBL] [Abstract][Full Text] [Related]
17. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.
Lawrenz T; Obergassel L; Lieder F; Leuner C; Strunk-Mueller C; Meyer Zu Vilsendorf D; Beer G; Kuhn H
Pacing Clin Electrophysiol; 2005 Apr; 28(4):295-300. PubMed ID: 15826262
[TBL] [Abstract][Full Text] [Related]
18. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
19. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?
Maron BJ; Olivotto I; Maron MS
Eur Heart J; 2006 Aug; 27(16):1895-7. PubMed ID: 16818455
[No Abstract] [Full Text] [Related]
20. Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
O'Mahony C; Elliott PM
Heart; 2014 Feb; 100(3):254-60. PubMed ID: 23574968
[No Abstract] [Full Text] [Related]
[Next] [New Search]
